E’Ola Ephedrine Hydrochloride Sales Barred Under FDA Settlement

FDA may order Biogenics, d/b/a E'Ola International, to "discontinue all manufacturing, processing, packing, labeling and distribution" if it believes the supplement marketer is selling a misbranded or adulterated product, according to a recent consent decree

More from Archive

More from Pink Sheet